Technical Analysis for TEVA - Teva Pharmaceutical Industries

Grade Last Price % Change Price Change
D 8.39 -0.36% -0.03
TEVA closed up 2.18 percent on Tuesday, December 7, 2021, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Flat
Historical TEVA trend table...

Date Alert Name Type % Chg
NR7 Range Contraction -0.42%
Oversold Stochastic Weakness -0.42%
New Downtrend Bearish 1.76%
Spinning Top Other 1.76%
Lower Bollinger Band Walk Weakness 1.76%
Oversold Stochastic Weakness 1.76%
New 52 Week Closing Low Bearish 4.16%
Lower Bollinger Band Walk Weakness 4.16%
New 52 Week Low Weakness 4.16%
Down 3 Days in a Row Weakness 4.16%
Older End-of-Day Signals for TEVA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
1.5x Volume Pace about 1 hour ago
10 DMA Support about 1 hour ago
Rose Above Previous Day's High about 1 hour ago
Possible NR7 about 21 hours ago
Up 2% about 22 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Teva Pharmaceutical Industries Description

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. It offers generic pharmaceutical products; and basic chemical entities, as well as specialized product families, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances. The company's principal branded pharmaceutical products comprise Copaxone for multiple sclerosis; Provigil and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorders; Azilect for the treatment of Parkinson's disease; Fentora and Actiq for the treatment of pain in opioid-tolerant adult patients with cancer; Amrix for muscle spasm in acute, painful, and musculoskeletal conditions; ProAir for the treatment of bronchial spasms; Qvar for long-term control of chronic bronchial asthma; and Qnasl Nasal Aerosol for seasonal nasal and year-round nasal allergy symptoms. The company also offers Treanda for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma; Tevagrastim/Ratiograstim that stimulate the production of white blood cells; Eporatio, which stimulates the production of red blood cells; Synribo for chronic myeloid leukemia; Plan B One-Step for emergency oral contraception; ParaGard, a non hormonal intrauterine contraceptive; hormone therapies for menopause/perimenopause; Enjuvia for vasomotor symptoms associated with menopause; and therapies for infertility and urinary incontinence. In addition, it produces active pharmaceutical ingredients in the areas of respiratory, cardiovascular, anti-cholesterol, central nervous system, dermatological, hormones, anti-inflammatory, oncology, immunosuppressants, and muscle relaxants. Further, the company distributes third party products. It has collaborative agreements with Lonza Group Ltd. and OncoGenex Pharmaceuticals, Inc. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Cancer Pharmaceutical Drugs Pain Medication Pharmaceutical Products Lymphoma Parkinson's Disease Opioid Symptoms Multiple Sclerosis Spas Asthma Leukemia Allergy Hormones MRI Cholesterol Active Pharmaceutical Ingredients Pharmaceutical Industries Fertility Red Blood Cell Treatment Of Parkinson's Disease Chronic Lymphocytic Leukemia Generic Pharmaceutical Lymphocytic Leukemia Sleep Apnea Infertility Obstructive Sleep Apnea Xone Blood Cells Chemical Entities Immunosuppressants Narcolepsy Hot Flash Petach Teva Pharmaceutical Industries Fentanyl Oncogene Party Products Urinary Incontinence Generic Pharmaceutical Products Muscle Spasm Treatment Of Chronic Lymphocytic Leukemia Bronchial Asthma Chronic Myeloid Leukemia Contraception Menopause Muscle Relaxants Nasal Allergy Spasms

Is TEVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.3
52 Week Low 7.94
Average Volume 9,887,676
200-Day Moving Average 9.97
50-Day Moving Average 9.33
20-Day Moving Average 8.80
10-Day Moving Average 8.38
Average True Range 0.30
ADX 26.18
+DI 14.97
-DI 28.15
Chandelier Exit (Long, 3 ATRs) 8.71
Chandelier Exit (Short, 3 ATRs) 8.83
Upper Bollinger Bands 9.78
Lower Bollinger Band 7.83
Percent B (%b) 0.3
BandWidth 22.19
MACD Line -0.32
MACD Signal Line -0.28
MACD Histogram -0.0394
Fundamentals Value
Market Cap 9.23 Billion
Num Shares 1.1 Billion
EPS 0.00
Price-to-Earnings (P/E) Ratio 2105.00
Price-to-Sales 0.64
Price-to-Book 1.11
PEG Ratio 1.25
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.68
Resistance 3 (R3) 8.66 8.55 8.63
Resistance 2 (R2) 8.55 8.49 8.56 8.62
Resistance 1 (R1) 8.49 8.44 8.52 8.51 8.60
Pivot Point 8.38 8.38 8.40 8.39 8.38
Support 1 (S1) 8.32 8.32 8.35 8.34 8.24
Support 2 (S2) 8.21 8.27 8.22 8.22
Support 3 (S3) 8.15 8.21 8.21
Support 4 (S4) 8.17